• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Scope It Out
MENU 
  • Home
  • About IFAR
  • About Dr. Smith
  • Episodes
  • Subscribe

Episode 116: Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study

October 22, 2026

In this episode, host Dr. Doug Reh speaks with Dr. Vijay Ramakrishnan. They discuss the recently published Original Article: “Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study.” The full manuscript is available as open access in the International Forum of Allergy and Rhinology.

Listen and subscribe for free to Scope It Out on Apple Podcasts, Google Podcasts and Subscribe on Android.

Scope It Out
Scope It Out
Episode 116: Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study
Loading
00:00 / 21:45
Apple Podcasts
RSS Feed
Share
Link
Embed

Download file | Play in new window | Duration: 21:45 | Recorded on October 20, 2026

Subscribe: Apple Podcasts

Tagged With: biologics, chronic rhinosinusitis, dupilumab, endoscopic sinus surgery, mepolizumab, nasal polyp, nasal polyposis, omalizumab, type 2 inflammation

Primary Sidebar

Visit Our Partners

American Academy of Otolaryngic AllergyInternational Forum of Allergy and RhinologyThe American Rhinologic Society

Sponsors

       Storz

  • Help & Support
  • About Us
  • Contact Us
  • Cookies & Privacy
  • Wiley Job Network
  • Cookie Preferences
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
Wiley